141 related articles for article (PubMed ID: 9729054)
1. Mometasone furoate decreases adhesion molecule expression in psoriasis.
Berti E; Cerri A; Marzano AV; Richelda R; Bianchi B; Caputo R
Eur J Dermatol; 1998 Sep; 8(6):421-6. PubMed ID: 9729054
[TBL] [Abstract][Full Text] [Related]
2. Decrease in enkephalin levels in psoriatic lesions after calcipotriol and mometasone furoate treatment.
Nissen JB; Avrach WW; Hansen ES; Stengaard-Pedersen K; Kragballe K
Dermatology; 1999; 198(1):11-7. PubMed ID: 10026395
[TBL] [Abstract][Full Text] [Related]
3. Cetirizine modulates adhesion molecule expression in a double-blind controlled study conducted in psoriatic patients.
Pestelli E; Floriani I; Fabbri P; Caproni M
Int J Tissue React; 2003; 25(1):1-8. PubMed ID: 12854881
[TBL] [Abstract][Full Text] [Related]
4. Response of cutaneous microcirculation to treatment with mometasone furoate in patients with psoriasis.
Stinco G; Lautieri S; Piccirillo F; Valent F; Patrone P
Clin Exp Dermatol; 2009 Dec; 34(8):915-9. PubMed ID: 19486040
[TBL] [Abstract][Full Text] [Related]
5. Tazarotene 0.1% gel in combination with mometasone furoate cream in plaque psoriasis: a photographic tracking study.
Poulin YP
Cutis; 1999 Jan; 63(1):41-8. PubMed ID: 9951595
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability, antipsoriatic efficacy and tolerability of a new light cream with mometasone furoate 0.1%.
Korting HC; Schöllmann C; Willers C; Wigger-Alberti W
Skin Pharmacol Physiol; 2012; 25(3):133-41. PubMed ID: 22353786
[TBL] [Abstract][Full Text] [Related]
7. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
[TBL] [Abstract][Full Text] [Related]
8. ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy.
Thomson AW; Nalesnik MA; Rilo HR; Woo J; Carroll PB; Van Thiel DH
Autoimmunity; 1993; 15(3):215-23. PubMed ID: 7505632
[TBL] [Abstract][Full Text] [Related]
9. Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris.
Tiplica GS; Salavastru CM
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):905-12. PubMed ID: 19470062
[TBL] [Abstract][Full Text] [Related]
10. Concentration-dependent effects of mometasone furoate and dexamethasone on foetal lung fibroblast functions involved in airway inflammation and remodeling.
Sabatini F; Silvestri M; Sale R; Serpero L; Giuliani M; Scarso L; Favini P; Rossi GA
Pulm Pharmacol Ther; 2003; 16(5):287-97. PubMed ID: 12877820
[TBL] [Abstract][Full Text] [Related]
11. Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study.
Koo J; Cuffie CA; Tanner DJ; Bressinck R; Cornell RC; DeVillez RL; Edwards L; Breneman DL; Piacquadio DJ; Guzzo CA; Monroe EW
Clin Ther; 1998; 20(2):283-91. PubMed ID: 9589819
[TBL] [Abstract][Full Text] [Related]
12. The effect of methotrexate on the expression of cell adhesion molecules and activation molecule CD69 in psoriasis.
Torres-Alvarez B; Castanedo-Cazares JP; Fuentes-Ahumada C; Moncada B
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):334-9. PubMed ID: 17309454
[TBL] [Abstract][Full Text] [Related]
13. The changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment.
Yazici AC; Tursen U; Apa DD; Ikizoglu G; Api H; Baz K; Tasdelen B
Arch Dermatol Res; 2005 Dec; 297(6):249-55. PubMed ID: 16215763
[TBL] [Abstract][Full Text] [Related]
14. Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge.
Ciprandi G; Tosca MA; Passalacqua G; Canonica GW
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):433-8. PubMed ID: 11345288
[TBL] [Abstract][Full Text] [Related]
15. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
[TBL] [Abstract][Full Text] [Related]
16. Cellular interactions and adhesion molecules in psoriatic skin.
de Boer OJ; Verhagen CE; Visser A; Bos JD; Das PK
Acta Derm Venereol Suppl (Stockh); 1994; 186():15-8. PubMed ID: 7915480
[TBL] [Abstract][Full Text] [Related]
17. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
Markham T; Mullan R; Golden-Mason L; Rogers S; Bresnihan B; Fitzgerald O; Fearon U; Veale DJ
J Am Acad Dermatol; 2006 Jun; 54(6):1003-12. PubMed ID: 16713454
[TBL] [Abstract][Full Text] [Related]
18. Topical calcipotriol for psoriasis--an immunohistologic study.
Mozzanica N; Cattaneo A; Schmitt E; Diotti R; Finzi AF
Acta Derm Venereol Suppl (Stockh); 1994; 186():171-2. PubMed ID: 7915481
[TBL] [Abstract][Full Text] [Related]
19. Effects of topical treatment with budesonide on parameters for epidermal proliferation, keratinization and inflammation in psoriasis.
de Jong EM; Ferrier CM; de Zwart A; Wauben-Penris PJ; Korstanje C; van de Kerkhof PC
J Dermatol Sci; 1995 May; 9(3):185-94. PubMed ID: 8664216
[TBL] [Abstract][Full Text] [Related]
20. Effects of topical calcipotriol on the expression of adhesion molecules in psoriasis.
Savoia P; Novelli M; De Matteis A; Verrone A; Bernengo MG
J Cutan Pathol; 1998 Feb; 25(2):89-94. PubMed ID: 9521497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
